Chemotherapy with gemcitabine in patients with advanced gallbladder carcinoma

Z Gastroenterol. 2000 Nov;38(11):909-12. doi: 10.1055/s-2000-10296.

Abstract

Background: Advanced or metastatic gallbladder carcinoma is regarded not much sensitive to chemotherapy. Standard chemotherapy regimens have not been established up to now.

Patients: We report on 5 patients with advanced gallbladder carcinoma who received chemotherapy with gemcitabine.

Results: Of these 5 patients, 3 demonstrated a partial remission and stable disease was achieved in another patient. Only one patient had no benefit from treatment with gemcitabine.

Conclusion: We conclude that gemcitabine may be an effective drug in the palliative treatment of gallbladder cancer, and thus its efficiency warrants evaluation in further studies.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antimetabolites, Antineoplastic / adverse effects
  • Chemotherapy, Adjuvant
  • Cholecystectomy
  • Deoxycytidine / administration & dosage*
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives
  • Female
  • Gallbladder Neoplasms / drug therapy*
  • Gallbladder Neoplasms / pathology
  • Gallbladder Neoplasms / surgery
  • Gemcitabine
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Gemcitabine